TrialsgrambetaRCTs are beautiful

ALLHAT

2002

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

In 33,357 hypertensive patients ≥ 55 with ≥ 1 CV risk factor, chlorthalidone was at least as effective as amlodipine or lisinopril for preventing fatal CHD or non-fatal MI.

Result

Primary endpoint: Fatal CHD or non-fatal MI

Primary endpoint similar across arms. Chlorthalidone better than lisinopril for stroke; better than amlodipine for HF.

Original publication
Subtopic
Drug class
Design
Double-blind RCT, mean 4.9 yr
Relevance
Important: one of several pillars.
Source
ALLHAT Officers. JAMA. 2002;288(23):2981-2997.doi 10.1001/jama.288.23.2981

Discussion & critique

Doxazosin arm stopped early for HF excess. Cemented thiazide-type diuretic as a reasonable first-line. Subgroup interpretations (black/non-black) shaped JNC/AHA guidance.

Discussed in podcasts